Aortic calcium scoring from single photon emission computed tomography to predict aortic stenosis and asses prognosis in patients with transthyretin cardiac amyloidosis

Back

HFA Premium Access

Aortic calcium scoring from single photon emission computed tomography to predict aortic stenosis and asses prognosis in patients with transthyretin cardiac amyloidosis

Session: Beating the odds: advances in cardiac amyloidosis treatment

Topic: Hypertrophic Cardiomyopathy

Speaker: Mr B. Guillaume (Toulouse, FR)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Mr Bonnans Guillaume

Toulouse Rangueil University Hospital of Toulouse, Toulouse (France)

0 follower

6 more presentations in this session

Cause of death in patients with transthyretin amyloid cardiomyopathy (ATTR-CM): findings from the ATTRibute-CM study

Speaker: Doctor L. Obici (Pavia, IT)

Effect of acoramidis on functional capacity and quality of life in patients with variant ATTR-CM: results from ATTRibute-CM

Speaker: Professor M. Fontana (London, GB)

Effect of acoramidis on all-cause mortality, cardiovascular hospitalization and NT-proBNP in variant ATTR-CM - results from ATTRibute-CM

Speaker: Professor M. Fontana (London, GB)

Acoramidis treatment is associated with a lower incidence of atrial fibrillation/atrial flutter events in patients with ATTR-CM: post-hoc analyses of the ATTRibute-CM trial

Speaker: Assistant Professor K. Alexander (Palo Alto, US)

Bioactive adrenomedullin as a predictor of clinical outcomes in cardiac transthyretin amyloidosis

Speaker: Mr M. Mueller (Berlin, DE)

Access the full session

Beating the odds: advances in cardiac amyloidosis treatment

Speakers: Mr B. Guillaume, Doctor L. Obici, Professor M. Fontana, Professor M. Fontana, Assistant Professor K. Alexander...

Access

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources